The pharmaceutical industry's adoption of artificial intelligence (AI) continues to expand, encompassing drug discovery, development, and clinical trials. Within this landscape, AstraZeneca stands out through its implementation of AI technology for clinical trials on a significant public health scale.
Unlike many competitors who primarily focus on optimizing internal research and development (R&D) pipelines, AstraZeneca's AI solutions have been directly integrated into national healthcare systems. This deployment enables the screening of hundreds of thousands of patients, concretely demonstrating AI's real-world impact on patients.